{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:45:11Z","timestamp":1786358711129,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.clbc.2021.02.012","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T09:07:10Z","timestamp":1615108030000},"page":"360-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Long-term Survival Comparison of Repeated Breast-conserving Surgery Versus Mastectomy for Patients with DCIS with Ipsilateral Breast Tumor Recurrence: A Real-world Longitudinal Study"],"prefix":"10.1016","volume":"21","author":[{"given":"Qing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianxue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2021.02.012_bib0001","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10549-013-2670-3","article-title":"Disease-free survival by treatment after a DCIS diagnosis in a population-based cohort study","volume":"141","author":"Sprague","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.012_bib0002","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10549-017-4330-5","article-title":"Incidence and treatments of DCIS in octogenarians: grade matters","volume":"165","author":"Ward","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.012_bib0003","first-page":"769","article-title":"Patient, tumor and therapeutic features related to recurrence of ductal carcinoma in situ (DCIS)","volume":"54","author":"Nistor-Ciurba","year":"2013","journal-title":"Rom J Morphol Embryol"},{"key":"10.1016\/j.clbc.2021.02.012_bib0004","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2021.02.012_bib0005","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10549-018-5048-8","article-title":"Time-varying risks of second events following a DCIS diagnosis in the population-based Vermont DCIS cohort","volume":"174","author":"Sprague","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.012_bib0006","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1200\/JCO.2008.19.8424","article-title":"Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer","volume":"27","author":"Anderson","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.012_bib0007","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.2005.04.3273","article-title":"Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials","volume":"24","author":"Wapnir","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.012_bib0008","doi-asserted-by":"crossref","first-page":"e818","DOI":"10.1634\/theoncologist.2018-0606","article-title":"Increased mortality with repeat lumpectomy alone after ipsilateral breast tumor recurrence","volume":"24","author":"Su","year":"2019","journal-title":"Oncologist"},{"key":"10.1016\/j.clbc.2021.02.012_bib0009","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12913-018-2882-7","article-title":"Re-excision and survival following breast conserving surgery in early stage breast cancer patients: a population-based study","volume":"18","author":"Fisher","year":"2018","journal-title":"BMC Health Ser Res"},{"key":"10.1016\/j.clbc.2021.02.012_bib0010","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijsu.2015.08.084","article-title":"Surgical management of ipsilateral breast tumor recurrence","volume":"23","author":"Kolben","year":"2015","journal-title":"Int J Surg"},{"key":"10.1016\/j.clbc.2021.02.012_bib0011","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamaoncol.2019.4320","article-title":"Effectiveness of breast-conserving surgery and 3-dimensional conformal partial breast reirradiation for recurrence of breast cancer in the ipsilateral breast: the NRG Oncology\/RTOG 1014 Phase 2 Clinical Trial","volume":"6","author":"Arthur","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2021.02.012_bib0012","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.amjsurg.2008.06.018","article-title":"The survival impact of the choice of surgical procedure after ipsilateral breast cancer recurrence","volume":"196","author":"Chen","year":"2008","journal-title":"Am J Surg"},{"key":"10.1016\/j.clbc.2021.02.012_bib0013","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2004.06.011","article-title":"Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer","volume":"61","author":"Galper","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2021.02.012_bib0014","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4048\/jbc.2015.18.4.386","article-title":"Independent prognostic factors for overall survival after salvage operation for ipsilateral breast tumor recurrence following breast-conserving surgery","volume":"18","author":"Lee","year":"2015","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.clbc.2021.02.012_bib0015","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1245\/s10434-012-2404-5","article-title":"Repeating conservative surgery after ipsilateral breast tumor reappearance: criteria for selecting the best candidates","volume":"19","author":"Gentilini","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.012_bib0016","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12957-016-0885-6","article-title":"Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer","volume":"14","author":"Choi","year":"2016","journal-title":"World Journal Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.012_bib0017","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s11427-018-9396-x","article-title":"Comparison of breast-conserving surgery and mastectomy in early breast cancer using observational data revisited: a propensity score-matched analysis","volume":"61","author":"Chen","year":"2018","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.clbc.2021.02.012_bib0018","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/tbj.13290","article-title":"Local recurrence of breast cancer: salvage lumpectomy as an option for local treatment","volume":"25","author":"Sellam","year":"2019","journal-title":"Breast J"},{"key":"10.1016\/j.clbc.2021.02.012_bib0019","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejso.2016.01.011","article-title":"Prognosis after mastectomy versus repeat lumpectomy in patients with ipsilateral breast cancer recurrence: a propensity score analysis","volume":"42","author":"Yoshida","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.012_bib0020","doi-asserted-by":"crossref","first-page":"e481","DOI":"10.1016\/j.clbc.2019.02.006","article-title":"A reappraisal of the comparative effectiveness of lumpectomy versus mastectomy on breast cancer survival: a propensity score-matched update from the National Cancer Data Base (NCDB)","volume":"19","author":"Landercasper","year":"2019","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2021.02.012_bib0021","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5306\/wjco.v11.i1.20","article-title":"Ipsilateral breast tumor recurrence in early stage breast cancer patients treated with breast conserving surgery and adjuvant radiation therapy: concordance of biomarkers and tumor location from primary tumor to in-breast tumor recurrence","volume":"11","author":"Purswani","year":"2020","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.02.012_bib0022","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/bjs.4344","article-title":"Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised","volume":"90","author":"Cochrane","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2021.02.012_bib0023","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00268-009-0278-x","article-title":"Cosmetic outcome and percentage of breast volume excision in oncoplastic breast conserving surgery","volume":"34","author":"Chan","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.clbc.2021.02.012_bib0024","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s13193-019-00973-y","article-title":"Correlation of specimen\/breast volume ratio to cosmetic outcome after breast conserving surgery","volume":"10","author":"Hashem","year":"2019","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.012_bib0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF02967437","article-title":"Radiation complications following breast conserving therapy","volume":"5","author":"Ikushima","year":"1998","journal-title":"Breast Cancer"},{"key":"10.1016\/j.clbc.2021.02.012_bib0026","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast","volume":"2010","author":"Correa","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.clbc.2021.02.012_bib0027","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ejso.2019.02.008","article-title":"Repeat breast-conserving therapy for ipsilateral breast cancer recurrence: a systematic review","volume":"45","author":"Walstra","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.012_bib0028","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5114\/jcb.2019.87001","article-title":"Second breast conserving therapy after ipsilateral breast tumor recurrence\u2013a 10-year experience of re-irradiation","volume":"11","author":"Forster","year":"2019","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.clbc.2021.02.012_bib0029","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.clbc.2012.09.006","article-title":"Outcome after ipsilateral breast tumor recurrence in patients with early-stage breast cancer treated with accelerated partial breast irradiation","volume":"12","author":"Shah","year":"2012","journal-title":"Clin Breast Cancer"},{"issue":"suppl 1","key":"10.1016\/j.clbc.2021.02.012_bib0030","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/j.critrevonc.2010.06.007","article-title":"Secondary malignancies in survivors of breast cancer: how to overcome the risk","volume":"84","author":"Shilkrut","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clbc.2021.02.012_bib0031","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/sj.bjc.6604524","article-title":"The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ","volume":"99","author":"Robinson","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2021.02.012_bib0032","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10549-017-4410-6","article-title":"Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers","volume":"166","author":"Withrow","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.012_bib0033","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s12253-018-0553-y","article-title":"Endocrine therapy for ductal carcinoma in situ (DCIS) of the breast with breast conserving surgery (BCS) and radiotherapy (RT): a meta-analysis","volume":"26","author":"Yan","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.clbc.2021.02.012_bib0034","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/s41416-019-0436-3","article-title":"The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution","volume":"120","author":"Miligy","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2021.02.012_bib0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10549-013-2755-z","article-title":"Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43","volume":"142","author":"Siziopikou","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.012_bib0036","doi-asserted-by":"crossref","first-page":"P685","DOI":"10.1016\/S1470-2045(20)30085-1","article-title":"Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07\/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial","volume":"21","author":"King","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2021.02.012_bib0037","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1245\/s10434-019-07537-y","article-title":"Comparison of local recurrence risk estimates after breast-conserving surgery for DCIS: DCIS nomogram versus refined Oncotype DX breast DCIS score","volume":"26","author":"Van Zee","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.02.012_bib0038","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10549-018-5020-7","article-title":"PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer","volume":"173","author":"Ohara","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.02.012_bib0039","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ajpath.2018.08.020","article-title":"Ductal carcinoma in situ biomarkers in a precision medicine era: current and future molecular-based testing","volume":"189","author":"Shee","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clbc.2021.02.012_bib0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.clbc.2018.07.018","article-title":"Including the ductal carcinoma-in-situ (DCIS) score in the development of a multivariable prediction model for recurrence after excision of DCIS","volume":"19","author":"Paszat","year":"2019","journal-title":"Clin Breast Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820921000550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820921000550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:23:35Z","timestamp":1761513815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820921000550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1526820921000550"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2021.02.012","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term Survival Comparison of Repeated Breast-conserving Surgery Versus Mastectomy for Patients with DCIS with Ipsilateral Breast Tumor Recurrence: A Real-world Longitudinal Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2021.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}